TCM
Tang Capital Management’s Immunocore IMCR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $66.1M | Buy |
2,105,608
+189,900
| +10% | +$5.96M | 3.34% | 4 |
|
|
2025
Q1 | $56.8M | Buy |
1,915,708
+360,108
| +23% | +$10.7M | 3.14% | 7 |
|
|
2024
Q4 | $45.9M | Buy |
1,555,600
+450,000
| +41% | +$13.3M | 3.04% | 7 |
|
|
2024
Q3 | $34.4M | Buy |
1,105,600
+700,000
| +173% | +$21.8M | 2.46% | 8 |
|
|
2024
Q2 | $13.7M | Hold |
405,600
| – | – | 1.4% | 24 |
|
|
2024
Q1 | $26.4M | Hold |
405,600
| – | – | 2.75% | 7 |
|
|
2023
Q4 | $27.7M | Hold |
405,600
| – | – | 2.56% | 10 |
|
|
2023
Q3 | $21.1M | Hold |
405,600
| – | – | 2.97% | 9 |
|
|
2023
Q2 | $24.3M | Hold |
405,600
| – | – | 3.58% | 5 |
|
|
2023
Q1 | $20.1M | Hold |
405,600
| – | – | 2.99% | 9 |
|
|
2022
Q4 | $23.1M | Hold |
405,600
| – | – | 3.36% | 8 |
|
|
2022
Q3 | $19M | Buy |
405,600
+20,000
| +5% | +$939K | 2.33% | 13 |
|
|
2022
Q2 | $14.4M | Hold |
385,600
| – | – | 2.18% | 15 |
|
|
2022
Q1 | $11.5M | Buy |
+385,600
| New | +$11.5M | 2.31% | 12 |
|